OncoTherapy Science, Inc. : Targeted therapy, Cancer peptide vaccines
Targeted therapy is a treatment for disease that works by zeroing in on specifically targeted molecules within the body and inhibiting their functions.
By identifying the differences between cancer cells and normal cells at the molecular or genetic information level, for example, this therapy is able to interfere only with those molecules that aid the growth and spread of cancer.
Conventional drugs have worked by identifying a broadly defined target, but targeted molecular therapy is different in that the target is very precisely identified and defined from the very earliest stages of drug development and treatment design. The level of accuracy with which the target cells are identified is extremely high.
At present, research is being conducted in this field for multiple diseases, including cancer, leukemia, rheumatoid arthritis, bronchitis, and asthma.
One of the most promising developments in cancer treatment is cancer peptide vaccine therapy. Japan is the undisputed world leader in this, and the high-level research being conducted by Professor Yusuke Nakamura and his team promises the establishment of new cancer therapies in the near future.
Until now, anti-cancer drugs have worked by attacking the cancer cells themselves, once they have already grown. By contrast, the cancer peptide vaccine identifies and attacks molecules that are related to the increase of cancer cells. This stops healthy cells becoming malignant.
OncoTherapy Science, Inc. is dedicated to the development of new anti-cancer medicines and cancer therapies, through the discovery of multiple molecular targets potentially suitable for the development of targeted therapies and medicines and the subsequent joint development of such therapies and drugs with external institutes based on its research findings.
Clinical research on cancer peptide vaccines is already being carried out in several institutes in Japan. OncoTherapy Science and its treatments and medicines continue to steadily progress, as the company works to improve treatment efficacy, reduce side effects, and turn the therapy into a treatment that can be received by any patients who wishes.
|OncoTherapy Science: Research Fields